About BiosparQ

BiosparQ B.V. is a privately-held in vitro diagnostics company dedicated to provide healthcare professionals with a unique solution for rapid diagnostics of infectious diseases that improves patient outcomes, lowers healthcare costs and helps turn back Antimicrobial Resistance (AMR).

BiosparQ has focused its efforts on research into and the development of the Cirrus D20 medical diagnostic platform, based on proprietary DigiTOF® technology. This technology enables direct analysis of patient samples using a Single-cell MALDI-TOF approach. DigiTOF® was initially developed by the TU Delft (Prof. J. Marijnissen et.al.) in co-operation with the Dutch Contract Research Organization TNO, under contracts of the US and Dutch Ministries of Defense in the early 2000s.

After incorporation and closing of seed funding rounds in 2009, BiosparQ began as a virtual company based in Delft. In 2012, a substantial series A round was closed, which enabled BiosparQ to grow into a fully integrated company.  All DigiTOF® assets from TU Delft / TNO was acquired (Patent portfolio and Cirrus D20 prototype hard- and software). It was decided move to the Leiden Bioscience Park, renting well equipped laboratories and offices from Biopartner foundation.

In 2016 a series B funding round was closed and in 2018 the company was granted an Innovation Credit by the Dutch government, enabling the company to mature the Cirrus D20 platform and develop, validate and certify the first applications.

Since 2009, the BiosparQ established an international network of clinical partners that support the company to create the applications pipeline. Several (inter)national subsidies were granted to the BiosparQ and its partners. In 2018, a supply chain consisting of high-tech suppliers was created to prepare for production qualification.

Contact

BiosparQ B.V.
Galileïweg 8
NL-2333 BD Leiden
The Netherlands

info@biosparq.nl

https://www.biosparq.nl

News items

Quantum future: Opportunities for microsystem technology – Micro Nano Symposium – POSTPONED

Quantum future: Opportunities for microsystem technology - Micro…

Quantum Network Explorer launch event

On 19 November QuTech is launching World’s first Quantum Network…

MinacNed extra General Assembly (ALV)

All representatives from MinacNed member organisations are invited…

EUREKA Subsidie zoekt voorstellen voor waterstof innovaties

Tot en met 4 november 2021 is het mogelijk om voorstellen in…
7 oktober 2021/door Aurélie Veltema

Invest-NL investeert in Delft IMP

Invest-NL neemt voor € 5 miljoen deel in een investeringsronde…
6 oktober 2021/door Aurélie Veltema

TEKNOWLOGY – NWO Innovation Festival

TEKNOWLOGY is hét festival waar technologie, wetenschap,…

Dutch Life Sciences Conference

The foremost life sciences business network event in the Netherlands
The…

Health Valley Event 2022

Zorginnovatiecongres
Wij werken er hard aan om in 2022 weer…

Maser Engineering en Eurofins Scientific bundelen krachten

MASER Engineering, het technologisch toonaangevende testcentrum…
5 oktober 2021/door Aurélie Veltema

Holland High Tech Event 2021

Het Holland High Tech EVENT op 2 november is hét jaarlijkse…

MinacNed presenteert: Micro Nano Sympsosia

In 2021 en 2022 organiseert MinacNed pre-events in de aanloop…
28 september 2021/door Aurélie Veltema

From Science to Market: Biomedical Production Technology – Micro Nano Symposium

Following the press conference from last Friday and the announced…